Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Statistics

Total Valuation

TPEX:6814 has a market cap or net worth of TWD 1.31 billion. The enterprise value is 1.41 billion.

Market Cap	1.31B
Enterprise Value	1.41B

Important Dates

The next estimated earnings date is Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6814 has 41.87 million shares outstanding. The number of shares has increased by 13.00% in one year.

Current Share Class	41.87M
Shares Outstanding	41.87M
Shares Change (YoY)	+13.00%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	7.71%
Owned by Institutions (%)	2.87%
Float	12.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.27
PB Ratio	4.63
P/TBV Ratio	4.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.63
EV / Sales	7.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.00

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.49.

Current Ratio	1.21
Quick Ratio	0.59
Debt / Equity	0.49
Debt / EBITDA	n/a
Debt / FCF	-1.56
Interest Coverage	-33.45

Financial Efficiency

Return on equity (ROE) is -29.03% and return on invested capital (ROIC) is -12.20%.

Return on Equity (ROE)	-29.03%
Return on Assets (ROA)	-11.43%
Return on Invested Capital (ROIC)	-12.20%
Return on Capital Employed (ROCE)	-25.80%
Revenue Per Employee	1.88M
Profits Per Employee	-1.00M
Employee Count	96
Asset Turnover	0.35
Inventory Turnover	1.93

Taxes

Income Tax	-95,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.23% in the last 52 weeks. The beta is 0.03, so TPEX:6814's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+17.23%
50-Day Moving Average	30.00
200-Day Moving Average	25.93
Relative Strength Index (RSI)	65.37
Average Volume (20 Days)	47,498

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6814 had revenue of TWD 180.32 million and -96.22 million in losses. Loss per share was -2.30.

Revenue	180.32M
Gross Profit	106.51M
Operating Income	-94.33M
Pretax Income	-96.32M
Net Income	-96.22M
EBITDA	-82.30M
EBIT	-94.33M
Loss Per Share	-2.30

Balance Sheet

The company has 40.28 million in cash and 137.59 million in debt, with a net cash position of -97.30 million or -2.32 per share.

Cash & Cash Equivalents	40.28M
Total Debt	137.59M
Net Cash	-97.30M
Net Cash Per Share	-2.32
Equity (Book Value)	283.31M
Book Value Per Share	6.77
Working Capital	18.60M

Cash Flow

In the last 12 months, operating cash flow was -77.29 million and capital expenditures -10.70 million, giving a free cash flow of -87.99 million.

Operating Cash Flow	-77.29M
Capital Expenditures	-10.70M
Free Cash Flow	-87.99M
FCF Per Share	-2.10

Margins

Gross margin is 59.06%, with operating and profit margins of -52.31% and -53.36%.

Gross Margin	59.06%
Operating Margin	-52.31%
Pretax Margin	-53.41%
Profit Margin	-53.36%
EBITDA Margin	-45.64%
EBIT Margin	-52.31%
FCF Margin	n/a

Dividends & Yields

TPEX:6814 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.00%
Shareholder Yield	-13.00%
Earnings Yield	-7.34%
FCF Yield	-6.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6814 has an Altman Z-Score of 3.14 and a Piotroski F-Score of 2.

Altman Z-Score	3.14
Piotroski F-Score	2